Horizon targets Depomed’s pain portfolio with $3B hostile bid – FiercePharma
Permalink

Horizon targets Depomed’s pain portfolio with $3B hostile bid – FiercePharma

The hostile $3 billion proposal was offered after DepoMed rejected a previous proposal made in…

Continue Reading →

Horizon Pharma offers to buy Depomed in $3 billion deal | Interactive Investor
Permalink

Horizon Pharma offers to buy Depomed in $3 billion deal | Interactive Investor

Shares in Depomed rocketed 37% as biopharmaceutical firm Horizon Phama said it was taking its…

Continue Reading →